Publication number: 20130297040
Abstract: The present invention relates to an implant comprising: —a core material comprising polydimethylsiloxane or at least one hydrogel polymer; —a tube encasing said core material comprising an ethylene vinyl acetate polymer or at least one hydrogel polymer; —a sealant for closure of the open ends of said tube comprising polydimethylsiloxane or a mono-, di-, or triacetoxy derivative thereof, or at least one hydrogel polymer; and —at least one active ingredient; wherein said at least one active ingredient is selected from the group comprising celecoxib, sulindac, tamoxifen, oestrogen, oestradiol, ethinyl oestradiol, mestranol, dienogest, norgestrel, levonorgestrel, desogestrel, norgestimate, ethynodiol diacetate, leuprorelin, buserelin, gonrelin, triptorelin, nafarelin, deslorelin, histrelin, and supprelin; and with the proviso that when the sealant is said at least one hydrogelpolymer, the core material comprises polydimethylsiloxane. Furthermore, the invention relates to an implant for use as a medicament.
Type:
Application
Filed:
January 16, 2012
Publication date:
November 7, 2013
Applicants:
UNIVERSITE DE LIEGE, UNIVERSITE CATHOLIQUE DE LOUVAIN
Inventors:
Jacques Donnez, Anne Van Langendonkt, Sylvie Defrère, Jean-Michel Foidart, Christine Jérome, Brigitte Evrard, Raphaël Riva, Fabrice Krier, Mélanie Mestdagt